A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy, and placebo plus leuprolide in men with high risk nonmetastatic prostate cancer progressing after definitive therapy

UCI-15-52
NCT02319837
Cancer - Prostate
Edward Uchio
Open
Treatment
Enzalutamide, Leuprolide
Drug therapy
3
Adult

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.